Showing results (311-320 of 599) with videos related to

Sort By:
Pageof 60
Scientific Reports|January 9, 2026
Distinct genomic, microenvironmental, and nephron signatures in VHL kidney cysts and tumorsIsaline Rowe, Francesca Corea, Giovanni B Pipitone, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 1, 2005
Primary CNS lymphoma of T-cell origin: a descriptive analysis from the international primary CNS lymphoma collaborative groupTamara N Shenkier, Jean-Yves Blay, Brian Patrick O'Neill, et al.
Diabetes|June 5, 2013
Autologous pancreatic islet transplantation in human bone marrowPaola Maffi, Gianpaolo Balzano, Maurilio Ponzoni, et al.
British Journal of Haematology|October 31, 2002
CXCL13 (BCA-1) is produced by follicular lymphoma cells: role in the accumulation of malignant B cellsHervé Husson, Arnold S Freedman, Angelo A Cardoso, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 19, 2013
IgG-switched CLL has a distinct immunogenetic signature from the common MD variant: ontogenetic implicationsAnna Vardi, Andreas Agathangelidis, Lesley-Ann Sutton, et al.
Hemasphere|October 9, 2024
Outcomes and prognostic factors in 3306 patients with relapsed/refractory chronic lymphocytic leukemia treated with ibrutinib outside of clinical trials: A nationwide studyGian Matteo Rigolin, Pier Paolo Olimpieri, Valentina Summa, et al.
Leukemia Research|May 22, 2012
Changes in the apoptotic gene expression profile in CLL patients treated with rituximab combined with cladribine and cyclophosphamide-preliminary resultsIda Franiak-Pietryga, Henryk Maciejewski, Dariusz Wolowiec, et al.
Leukemia|May 25, 2022
Immunoglobulin gene sequence analysis in chronic lymphocytic leukemia: the 2022 update of the recommendations by ERIC, the European Research Initiative on CLLAndreas Agathangelidis, Anastasia Chatzidimitriou, Thomas Chatzikonstantinou, et al.
Blood|April 16, 2021
Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with chronic lymphocytic leukemiaYair Herishanu, Irit Avivi, Anat Aharon, et al.
ESMO Open|October 12, 2018
BET bromodomain inhibitor birabresib in mantle cell lymphoma: in vivo activity and identification of novel combinations to overcome adaptive resistanceChiara Tarantelli, Elena Bernasconi, Eugenio Gaudio, et al.
Pageof 60